US3740421A
(en)
|
1966-09-19 |
1973-06-19 |
Basf Wyandotte Corp |
Polyoxyethylene-polyoxypropylene aqueous gels
|
EP0027888B1
(en)
|
1979-09-21 |
1986-04-16 |
Hitachi, Ltd. |
Semiconductor switch
|
US4673574A
(en)
|
1981-08-31 |
1987-06-16 |
Anderson Porter W |
Immunogenic conjugates
|
US4902506A
(en)
|
1983-07-05 |
1990-02-20 |
The University Of Rochester |
Immunogenic conjugates
|
US4709017A
(en)
|
1985-06-07 |
1987-11-24 |
President And Fellows Of Harvard College |
Modified toxic vaccines
|
US4950740A
(en)
|
1987-03-17 |
1990-08-21 |
Cetus Corporation |
Recombinant diphtheria vaccines
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
DE68907045T2
(de)
|
1989-01-17 |
1993-12-02 |
Eniricerche Spa |
Synthetische Peptide und deren Verwendung als allgemeine Träger für die Herstellung von immunogenischen Konjugaten, die für die Entwicklung von synthetischen Impfstoffen geeignet sind.
|
HU212924B
(en)
|
1989-05-25 |
1996-12-30 |
Chiron Corp |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
JPH04506662A
(ja)
|
1989-07-14 |
1992-11-19 |
アメリカン・サイアナミド・カンパニー |
接合体ワクチンのためのサイトカイニンおよびホルモンのキヤリヤー
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
SE466259B
(sv)
|
1990-05-31 |
1992-01-20 |
Arne Forsgren |
Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
|
EP0471177B1
(en)
|
1990-08-13 |
1995-10-04 |
American Cyanamid Company |
Filamentous hemagglutinin of bordetella pertussis as a carrier molecule for conjugate vaccines
|
CA2059693C
(en)
|
1991-01-28 |
2003-08-19 |
Peter J. Kniskern |
Polysaccharide antigens from streptococcus pneumoniae
|
CA2059692C
(en)
|
1991-01-28 |
2004-11-16 |
Peter J. Kniskern |
Pneumoccoccal polysaccharide conjugate vaccine
|
ATE245446T1
(de)
|
1992-02-11 |
2003-08-15 |
Jackson H M Found Military Med |
Dualer träger für immunogene konstrukte
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
ES2130265T3
(es)
|
1992-05-06 |
1999-07-01 |
Harvard College |
Region de union al receptor de la toxina difterica.
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
ATE280235T1
(de)
|
1993-03-05 |
2004-11-15 |
Wyeth Corp |
Plasmid zur herstellung von crm-protein und diphtherie-toxin
|
KR100376361B1
(ko)
|
1993-09-22 |
2003-07-18 |
헨리 엠. 잭슨 파운데이션 포 더 어드벤스먼트 오브 밀리터리 메디신 |
면역원성구조체의제조를위하여신규한시아닐레이팅시약을사용하여용해성탄수화물을활성화하는방법
|
US6455673B1
(en)
|
1994-06-08 |
2002-09-24 |
President And Fellows Of Harvard College |
Multi-mutant diphtheria toxin vaccines
|
US5917017A
(en)
|
1994-06-08 |
1999-06-29 |
President And Fellows Of Harvard College |
Diphtheria toxin vaccines bearing a mutated R domain
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
WO1996029094A1
(en)
|
1995-03-22 |
1996-09-26 |
Andrew Lees |
Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents
|
AU6095196A
(en)
|
1995-06-06 |
1996-12-24 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Dual carrier immunogenic construct
|
DE69739981D1
(de)
|
1996-10-31 |
2010-10-14 |
Human Genome Sciences Inc |
Streptococcus pneumoniae-Antigene und Impfstoffe
|
KR19980067137A
(ko)
|
1997-01-31 |
1998-10-15 |
박원훈 |
알긴산염 초미세과립구를 이용한 폐렴구균 감연중에 대한 백신
|
US6299881B1
(en)
|
1997-03-24 |
2001-10-09 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
|
US6113918A
(en)
|
1997-05-08 |
2000-09-05 |
Ribi Immunochem Research, Inc. |
Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
US6146902A
(en)
|
1998-12-29 |
2000-11-14 |
Aventis Pasteur, Inc. |
Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
|
JP2002540074A
(ja)
|
1999-03-19 |
2002-11-26 |
スミスクライン ビーチャム バイオロジカルズ ソシエテ アノニム |
ワクチン
|
WO2000061761A2
(en)
|
1999-04-09 |
2000-10-19 |
Techlab, Inc. |
Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
|
GB0007432D0
(en)
|
2000-03-27 |
2000-05-17 |
Microbiological Res Authority |
Proteins for use as carriers in conjugate vaccines
|
MXPA03000103A
(es)
|
2000-06-20 |
2003-06-19 |
Shire Biochem Inc |
Antigenos de streptococcus.
|
ES2375704T5
(es)
|
2000-06-29 |
2016-03-03 |
Smithkline Beecham Biologicals S.A. |
Composición de vacuna multivalente
|
ES2359625T3
(es)
|
2000-12-28 |
2011-05-25 |
Wyeth Llc |
Proteina protectora recombinante de.
|
EP1572868A4
(en)
|
2001-04-16 |
2007-04-04 |
Wyeth Corp |
NOVEL OPEN READING FRAMES OF STREPTOCOCCUS PNEUMONIAE ENCODING POLYPEPTIDE ANTIGENS AND USES THEREOF
|
US20030035806A1
(en)
|
2001-05-11 |
2003-02-20 |
D'ambra Anello J. |
Novel meningitis conjugate vaccine
|
GB0118249D0
(en)
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
AU2002330681C1
(en)
|
2001-07-26 |
2015-04-02 |
Glaxosmithkline Biologicals S.A. |
Vaccines comprising aluminium adjuvants and histidine
|
AU2002351623A1
(en)
|
2001-12-20 |
2003-07-09 |
Shire Biochem Inc. |
Streptococcus antigens
|
FR2850106B1
(fr)
|
2003-01-17 |
2005-02-25 |
Aventis Pasteur |
Conjugues obtenus par amination reductrice du polysaccharide capsulaire du pneumocoque de serotype 5
|
KR20050110628A
(ko)
|
2003-02-10 |
2005-11-23 |
엘란 파마슈티칼스, 인크. |
면역글로불린 제제 및 이의 제조방법
|
DE602004010376T2
(de)
|
2003-03-13 |
2008-10-23 |
Glaxosmithkline Biologicals S.A. |
Verfahren zur reinigung von bakteriellem cytolysin
|
EP1603950A2
(en)
|
2003-03-17 |
2005-12-14 |
Wyeth Holdings Corporation |
Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
|
AU2003901717A0
(en)
|
2003-04-10 |
2003-05-01 |
Western Sydney Area Health Service |
Identification of streptococcus pneumoniae serotypes
|
US20090317412A1
(en)
|
2004-06-04 |
2009-12-24 |
Alexander Jeffery L |
Induction of an immune response against streptococcus pneumoniae polyaccharides
|
MX2007007291A
(es)
|
2004-12-16 |
2007-08-22 |
Stichting Top Inst Food And Nu |
Procedimiento de produccion eficiente novedoso para polisacaridos capsulares de bacterias gram positivas patogenas mediante expresion heterologa y secrecion de polisacaridos complejos en bacterias gram positivas no patogenas, no invasivas.
|
EP2425855A1
(en)
|
2005-04-08 |
2012-03-07 |
Wyeth LLC |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
US7709001B2
(en)
|
2005-04-08 |
2010-05-04 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
ES2707202T3
(es)
|
2005-04-08 |
2019-04-02 |
Wyeth Llc |
Separación de contaminantes de polisacárido de Streptococcus pneumoniae por manipulación del pH
|
US20070184072A1
(en)
|
2005-04-08 |
2007-08-09 |
Wyeth |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
US7955605B2
(en)
|
2005-04-08 |
2011-06-07 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
US7764278B2
(en)
|
2005-06-30 |
2010-07-27 |
Seiko Epson Corporation |
Integrated circuit device and electronic instrument
|
MY148141A
(en)
|
2005-12-22 |
2013-03-15 |
Glaxosmithkline Biolog Sa |
Vaccine
|
AU2006336520B2
(en)
|
2005-12-28 |
2011-09-15 |
The Uab Research Foundation |
Pneumococcal serotypes
|
US8481054B2
(en)
|
2005-12-28 |
2013-07-09 |
The UAB Foundation |
Pneumococcal serotypes
|
TW200806315A
(en)
|
2006-04-26 |
2008-02-01 |
Wyeth Corp |
Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
|
US8808707B1
(en)
|
2006-05-08 |
2014-08-19 |
Wyeth Llc |
Pneumococcal dosing regimen
|
EP2056871B1
(en)
|
2006-08-07 |
2017-11-15 |
President and Fellows of Harvard College |
Protein matrix vaccines and methods of making and administering such vaccines
|
CN101522906B
(zh)
|
2006-10-10 |
2012-05-30 |
惠氏公司 |
肺炎链球菌3型多糖的纯化
|
US8652480B2
(en)
|
2007-03-23 |
2014-02-18 |
Wyeth Llc |
Shortened purification process for the production of capsular Streptococcus pneumoniae polysaccharides
|
EP2167120A2
(en)
|
2007-06-26 |
2010-03-31 |
GlaxoSmithKline Biologicals S.A. |
Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
|
US8540955B2
(en)
|
2007-07-10 |
2013-09-24 |
Wyeth Llc |
Process for producing aluminum phosphate
|
CN102257127B
(zh)
|
2008-12-18 |
2014-01-01 |
惠氏有限责任公司 |
使用二氧化碳控制肺炎链球菌多糖分子量的方法
|
DK2379734T3
(en)
|
2008-12-18 |
2018-04-23 |
Wyeth Llc |
Method for Controlling the Molecular Weight of Polysaccharide of Streptococcus Pneumoniae Serotype 19A
|
CN101590224A
(zh)
|
2009-06-30 |
2009-12-02 |
广州精达医学科技有限公司 |
高效14价肺炎球菌结合疫苗
|
KR20120104178A
(ko)
|
2009-09-09 |
2012-09-20 |
메트리박스 리써치 앤 디벨롭먼트 코포레이션 |
면역원성이 개선된 단백질 매트릭스 백신
|
GB0917647D0
(en)
|
2009-10-08 |
2009-11-25 |
Glaxosmithkline Biolog Sa |
Expression system
|
TW201136603A
(en)
|
2010-02-09 |
2011-11-01 |
Merck Sharp & Amp Dohme Corp |
15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
|
GB201003924D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
GB201003922D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
CN102933229A
(zh)
|
2010-06-04 |
2013-02-13 |
惠氏有限责任公司 |
疫苗制剂
|
EP2648506A1
(en)
|
2010-12-10 |
2013-10-16 |
Merck Sharp & Dohme Corp. |
Novel formulations which mitigate agitation-induced aggregation of immunogenic compositions
|
CN102068690A
(zh)
|
2010-12-31 |
2011-05-25 |
北京民海生物科技有限公司 |
多价肺炎球菌荚膜多糖结合疫苗及其制备方法
|
GB201103836D0
(en)
|
2011-03-07 |
2011-04-20 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
EP3524265A1
(en)
|
2011-05-18 |
2019-08-14 |
Matrivax, Inc. |
Protein matrix vaccine compositions including polycations
|
CN103732610A
(zh)
|
2011-06-13 |
2014-04-16 |
默沙东公司 |
纯化天然或突变体形式的白喉毒素的方法
|
KR102057217B1
(ko)
|
2012-06-20 |
2020-01-22 |
에스케이바이오사이언스 주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
CN103623401A
(zh)
|
2012-08-23 |
2014-03-12 |
北京科兴中维生物技术有限公司 |
多价肺炎球菌荚膜多糖-蛋白质共轭组合物及其制备方法
|
CN103656631B
(zh)
*
|
2012-09-24 |
2015-08-19 |
北京科兴中维生物技术有限公司 |
多价肺炎球菌荚膜多糖-蛋白缀合物组合物及其制备方法
|
CN103656632B
(zh)
|
2012-09-24 |
2016-01-13 |
北京科兴中维生物技术有限公司 |
多价肺炎球菌荚膜多糖组合物、其制备方法及应用
|
KR20140075201A
(ko)
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
KR20140075196A
(ko)
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
WO2014097099A2
(en)
|
2012-12-20 |
2014-06-26 |
Pfizer Inc. |
Glycoconjugation process
|
ITMI20130142A1
(it)
|
2013-01-31 |
2014-08-01 |
Biosynth Srl |
Vaccini glicoconiugati comprendenti unita' di base di un costrutto molecolare esprimente epitopi multipli incorporati
|
CN104069488A
(zh)
|
2013-03-29 |
2014-10-01 |
北京科兴中维生物技术有限公司 |
多价肺炎球菌荚膜多糖-蛋白质共轭组合物及其制备方法
|
KR20210032013A
(ko)
*
|
2014-01-21 |
2021-03-23 |
화이자 인코포레이티드 |
스트렙토코쿠스 뉴모니아에 피막 폴리사카라이드 및 그의 접합체
|
BR112016015525A2
(pt)
*
|
2014-01-21 |
2017-10-24 |
Pfizer |
composições imunogênicas compreendendo antígenos sacarídeos capsulares conjugados e uso
|
EP3096783B1
(en)
|
2014-01-21 |
2021-07-07 |
Pfizer Inc. |
Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
|
DK3244917T3
(da)
|
2015-01-15 |
2023-05-22 |
Pfizer |
Immunogene sammensætninger til anvendelse i pneumokokvacciner
|
NZ736238A
(en)
|
2015-05-04 |
2022-07-01 |
Pfizer |
Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
|
MX2017015985A
(es)
|
2015-06-08 |
2018-08-15 |
Serum Inst Of India Private Ltd |
Metodos para mejorar la adsorcion de conjugados de polisacarido-proteina y formulacion de vacuna multivalente obtenida con los mismos.
|
WO2016207905A2
(en)
|
2015-06-23 |
2016-12-29 |
Biological E Limited |
Multivalent pneumococcal conjugate vaccine
|
WO2017011338A1
(en)
|
2015-07-10 |
2017-01-19 |
President And Fellows Of Harvard College |
Sortase-mediated coupling of immunogenic polysaccharide-protein conjugates and their use
|
IL303998A
(en)
|
2015-07-21 |
2023-08-01 |
Pfizer |
Immunogenic preparations containing conjugated capsular sugar antigens, kits containing them and their uses
|
GB201518684D0
(en)
|
2015-10-21 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Vaccine
|
BR112018008864A8
(pt)
|
2015-11-17 |
2019-02-26 |
Pfizer |
meios e métodos de fermentação para a produção de polissacarídeos em uma cultura de células bacterianas
|
EP3377098A1
(en)
|
2015-11-20 |
2018-09-26 |
Pfizer Inc |
Immunogenic compositions for use in pneumococcal vaccines
|
WO2017173415A2
(en)
*
|
2016-03-31 |
2017-10-05 |
Liffey Biotech Limited |
Saccharide-polypeptide conjugate compositions and methods of use thereof
|
WO2017220753A1
(en)
|
2016-06-22 |
2017-12-28 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pneumococcal polysaccharide-protein conjugate composition
|
CN105999254A
(zh)
|
2016-06-27 |
2016-10-12 |
北京智飞绿竹生物制药有限公司 |
含2型和12f血清型的15价肺炎球菌结合物组合疫苗
|
WO2018009906A1
(en)
|
2016-07-08 |
2018-01-11 |
President And Fellows Of Harvard College |
Whole cell-protein conjugates and methods of making the same
|
EP3491856A4
(en)
|
2016-07-27 |
2020-01-22 |
Sharp Kabushiki Kaisha |
WIRELESS TELECOMMUNICATION METHODS AND APPARATUS USING SYSTEM INFORMATION VALUE LABEL
|
MX2019001342A
(es)
|
2016-08-05 |
2019-07-04 |
Sanofi Pasteur Inc |
Composicion de conjugado de proteina-polisacarido de neumococo multivalente.
|
EA039427B1
(ru)
|
2016-08-05 |
2022-01-26 |
Санофи Пастер Инк. |
Поливалентная пневмококковая полисахаридно-белковая конъюгатная композиция
|
MA45283B1
(fr)
|
2016-09-06 |
2021-05-31 |
Lg Chemical Ltd |
Une composition de multivalent pneumococcal la protéine de polysaccaride-transporteur capsulaire se conjugue et utilisez de cela
|
NZ752348A
(en)
|
2016-09-30 |
2022-11-25 |
Biological E Ltd |
Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates
|
KR20180043122A
(ko)
|
2016-10-19 |
2018-04-27 |
동국대학교 산학협력단 |
신규링커를 통한 폐렴구균 다당류-단백질 접합체 백신 및 이의 용도
|
KR102083973B1
(ko)
|
2016-10-28 |
2020-04-23 |
주식회사 엘지화학 |
향상된 IgG 역가를 갖는 다가면역원성 조성물 및 이의 용도
|
CN108144056A
(zh)
|
2016-12-02 |
2018-06-12 |
武汉博沃生物科技有限公司 |
多价肺炎球菌多糖结合疫苗及其制备方法
|
EP3570879B1
(en)
|
2017-01-20 |
2022-03-30 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
CN116870144A
(zh)
|
2017-01-31 |
2023-10-13 |
默沙东有限责任公司 |
制备多糖-蛋白缀合物的方法
|
CN110225757A
(zh)
|
2017-01-31 |
2019-09-10 |
默沙东公司 |
由肺炎链球菌血清型19f生产荚膜多糖蛋白缀合物的方法
|
WO2018156465A1
(en)
|
2017-02-24 |
2018-08-30 |
Merck Sharp & Dohme Corp. |
Polysaccharide-protein conjugates utilizing diphtheria toxin fragment b as a carrier
|
US11090374B2
(en)
|
2017-02-24 |
2021-08-17 |
Merck Sharp & Dohme Corp. |
Enhancing immunogenicity of Streptococcus pneumoniae polysaccharide-protein conjugates
|
US20200061542A1
(en)
|
2017-02-24 |
2020-02-27 |
Merck Sharp & Dohme Corp. |
Methods for improving filterability of polysaccharide-protein conjugate reactions
|
WO2018156468A1
(en)
|
2017-02-24 |
2018-08-30 |
Merck Sharp & Dohme Corp. |
Pneumococcal conjugate vaccine formulations
|
WO2018169303A1
(ko)
|
2017-03-15 |
2018-09-20 |
주식회사 엘지화학 |
다가 폐렴구균 백신 조성물
|
CN107929728A
(zh)
|
2017-04-19 |
2018-04-20 |
武汉博沃生物科技有限公司 |
一种肺炎球菌蛋白疫苗及其制备方法
|
BR112019026192B1
(pt)
|
2017-06-10 |
2022-05-10 |
Inventprise, Llc |
Vacinas de conjugado multivalente com polissacarídeos de conjugado bivalente ou multivalente que fornecem imunogenicidade e avidez melhoradas
|
CN109091668A
(zh)
|
2017-06-20 |
2018-12-28 |
浙江博和瑞达生物科技有限公司 |
16价肺炎链球菌结合疫苗组合物
|
US20200360500A1
(en)
|
2017-08-16 |
2020-11-19 |
Merck Sharp & Dohme Corp. |
Pneumococcal conjugate vaccine formulations
|
BR112020004410A8
(pt)
|
2017-09-07 |
2023-01-31 |
Merck Sharp & Dohme |
Processos para a formulação de polissacarídeos pneumocócicos para conjugação a uma proteína carreadora
|
AU2018328038B2
(en)
|
2017-09-07 |
2024-03-07 |
Merck Sharp & Dohme Llc |
Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
|
US11395849B2
(en)
|
2017-09-07 |
2022-07-26 |
Merck Sharp & Dohme Llc |
Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
|
JP7438102B2
(ja)
|
2017-09-07 |
2024-02-26 |
メルク・シャープ・アンド・ドーム・エルエルシー |
肺炎球菌多糖体および免疫原性多糖体-キャリアタンパク質コンジュゲートでのその使用
|
BR112020004396A8
(pt)
|
2017-09-07 |
2023-01-31 |
Merck Sharp & Dohme |
Polissacarídeos pneumocócicos e uso dos mesmos em conjugados imunogênicos polissacarídeo-proteína carreadora
|
EP3691677A4
(en)
|
2017-10-04 |
2021-07-07 |
Pogona, Llc |
COMPOSITIONS OF SACCHARIDE-POLYPEPTIDE CONJUGATES AND THEIR METHODS OF USE
|
EP3700565A4
(en)
|
2017-10-25 |
2021-09-29 |
Merck Sharp & Dohme Corp. |
ADJUVED VACCINES
|
JP2019118051A
(ja)
|
2017-12-27 |
2019-07-18 |
株式会社デンソー |
表示処理装置
|
CN108159408A
(zh)
|
2017-12-29 |
2018-06-15 |
云南沃森生物技术股份有限公司 |
一种多价肺炎球菌多糖-蛋白结合物组合物及其制备方法和应用
|
CN108245674A
(zh)
|
2018-01-18 |
2018-07-06 |
北京智飞绿竹生物制药有限公司 |
一种多价肺炎球菌结合物组合疫苗的处方及其制备方法
|
CN108079286B
(zh)
|
2018-01-19 |
2020-07-31 |
云南沃森生物技术股份有限公司 |
一种13价肺炎球菌多糖-蛋白结合物组合物及其制备方法和应用
|
SG11202006388SA
(en)
|
2018-02-05 |
2020-07-29 |
Sanofi Pasteur Inc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
AU2019215212A1
(en)
|
2018-02-05 |
2020-07-23 |
Sk Bioscience Co., Ltd. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
WO2019170068A1
(zh)
|
2018-03-05 |
2019-09-12 |
武汉博沃生物科技有限公司 |
一种肺炎链球菌疫苗及其制备方法
|
CN111989114A
(zh)
|
2018-04-18 |
2020-11-24 |
Sk生物科学株式会社 |
肺炎链球菌的荚膜多糖以及其免疫原性缀合物
|
CN112074293A
(zh)
|
2018-04-30 |
2020-12-11 |
默沙东公司 |
生产肺炎链球菌荚膜多糖载体蛋白缀合物的方法
|
EP3788143B1
(en)
|
2018-04-30 |
2023-06-28 |
Merck Sharp & Dohme LLC |
Methods for providing a homogenous solution of lyophilized mutant diptheria toxin in dimethylsulfoxide
|
JP2021522285A
(ja)
|
2018-04-30 |
2021-08-30 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
リオスフィアから肺炎連鎖球菌莢膜多糖類キャリアタンパク質コンジュゲートを生産する方法
|
EP3791121A4
(en)
|
2018-05-07 |
2022-01-05 |
Merck Sharp & Dohme Corp. |
FREEZE-DRYING BAG
|
CN108339115B
(zh)
|
2018-05-11 |
2020-07-10 |
武汉博沃生物科技有限公司 |
使用重组载体蛋白的肺炎球菌联合疫苗及其制备方法
|
WO2019220304A1
(en)
|
2018-05-14 |
2019-11-21 |
Tergene Biotech Pvt. Ltd. |
15 valent pneumococcal polysaccharide conjugate vaccine
|
EP3801469A4
(en)
|
2018-06-07 |
2022-03-09 |
Merck Sharp & Dohme Corp. |
KIT OF CRITICAL REAGENTS IN THE FORM OF LYOSPHERES
|
CN108524926B
(zh)
|
2018-06-29 |
2021-06-29 |
康希诺生物股份公司 |
一种多价肺炎球菌结合疫苗的制剂组合及其应用
|
WO2020009462A1
(ko)
|
2018-07-06 |
2020-01-09 |
주식회사 유바이오로직스 |
다가 폐렴구균 다당체-단백질 접합체를 포함하는 면역원성 조성물, 및 이를 포함하는 폐렴구균에 의한 질환 예방 백신
|
CN108543066A
(zh)
|
2018-07-17 |
2018-09-18 |
成都安特金生物技术有限公司 |
一种24价肺炎球菌多糖疫苗及其鉴别方法
|
WO2020021416A1
(en)
|
2018-07-21 |
2020-01-30 |
Biological E Limited |
Vaccine formulations comprising preservative system
|
CN113164581A
(zh)
|
2018-09-23 |
2021-07-23 |
生物E有限公司 |
纯化的肺炎链球菌荚膜多糖
|
BR112021012521A2
(pt)
|
2018-10-12 |
2021-09-14 |
Biological E Limited |
Vacina conjugada de polissacarídeo-proteína pneumocócica multivalente
|
CN109336989B
(zh)
|
2018-10-22 |
2022-05-13 |
北京智飞绿竹生物制药有限公司 |
一种通过粘度控制制备肺炎球菌荚膜多糖的方法
|
CA3120922A1
(en)
|
2018-12-12 |
2020-06-18 |
Pfizer Inc. |
Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and uses thereof
|
US11642406B2
(en)
|
2018-12-19 |
2023-05-09 |
Merck Sharp & Dohme Llc |
Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
|
WO2020152706A1
(en)
|
2019-01-21 |
2020-07-30 |
Biological E Limited |
Multivalent pneumococcal conjugate vaccine compositions
|
WO2020157772A1
(en)
|
2019-01-28 |
2020-08-06 |
Biological E Limited |
Multivalent pneumococcal polysaccharide-protein conjugate vaccine compositions
|
CN109771640A
(zh)
|
2019-02-28 |
2019-05-21 |
北京智飞绿竹生物制药有限公司 |
多价肺炎球菌结合疫苗
|
CA3136278A1
(en)
|
2019-04-10 |
2020-10-15 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
|
KR20220016964A
(ko)
|
2019-06-05 |
2022-02-10 |
머크 샤프 앤드 돔 코포레이션 |
에스. 뉴모니아에 혈청형 29에 대해 보호하는 면역원성 조성물을 사용하여 환자를 치료하는 방법
|
JP2022535063A
(ja)
|
2019-06-05 |
2022-08-04 |
メルク・シャープ・アンド・ドーム・コーポレーション |
免疫原性血清型35b肺炎球菌多糖類-タンパク質コンジュゲート及びそれを作成するためのコンジュゲーションプロセス
|
CN110302375A
(zh)
|
2019-06-27 |
2019-10-08 |
康希诺生物股份公司 |
一种糖缀合物及其用途
|
CN110365663A
(zh)
|
2019-06-28 |
2019-10-22 |
北京淇瑀信息科技有限公司 |
一种隔离集群之间的访问方法、装置及电子设备
|
TW202116352A
(zh)
|
2019-07-18 |
2021-05-01 |
南韓商賽特瑞恩股份有限公司 |
包含多價肺炎球菌多醣-蛋白共軛物的免疫組成物、醫藥組成物及其用途
|
AU2020323498A1
(en)
|
2019-07-31 |
2022-03-03 |
Sk Bioscience Co., Ltd. |
Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
|
CN111821432B
(zh)
|
2020-08-05 |
2022-10-18 |
北京智飞绿竹生物制药有限公司 |
一种多价肺炎球菌结合疫苗
|